Dr Josep M Llibre, MD, PhD, received his MD in the Universitat de Barcelona, and obtained his specialty in Internal Medicine and his PhD in the Universitat Autònoma de Barcelona with his research on the Clinical Impact of HIV resistance against non-nucleoside reverse transcriptase inhibitors. He does clinical assistance and clinical research in the Infectious Diseases Dept. of the Germans Trias I Pujol University Hospital in Barcelona.
He has been a panel member of the Antiretroviral treatment guidelines at the GeSIDA group (AIDS group of the SEIMC Spanish society), and an expert advisor of the Catalan Health Institute (ICS) on antiretroviral treatment and hepatitis C (PADEICS). He started caring for patients with HIV/AIDS at the beginning of the epidemic in Spain in 1987. His main areas of interest in HIV Medicine include the clinical implications of HIV-1 resistance, the analysis of safety and efficacy in HIV-1 antiretroviral treatment clinical trials (both in naïve and pre-treated patients), with special interest in drug efficacy, new treatment strategies and pharmaco-economics.
He has published widely in journals and book chapters, as well as HIV/AIDS medical webs, on clinical aspects of HIV-1 treatment and care, HIV-1 resistance, clinical reviews, positioning papers, treatment intensification and simplification strategies, and participated in many pivotal clinical trials. He has also published in basic science research journals.
He collaborates as an editor and/or peer reviewing with many top international medical journals.
He is involved in HIV Medical Educational training in Spain and other European countries, and has participated in long-distance expert advice support strategies for complex HIV patients in Spain.
